Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Retrospective comparison of early versus late treatment with fluticasone propionate/salmeterol after an asthma exacerbation.

Hagiwara M, Delea TE, Stanford RH.

J Asthma. 2011 Sep;48(7):721-8. doi: 10.3109/02770903.2011.599908. Epub 2011 Jul 28.

PMID:
21793768
3.

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.

Curr Med Res Opin. 2009 Jan;25(1):1-13. doi: 10.1185/03007990802534020 .

PMID:
19210134
4.

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.

Delea TE, Stanford RH, Hagiwara M, Stempel DA.

Curr Med Res Opin. 2008 Dec;24(12):3435-42. doi: 10.1185/03007990802557344 .

PMID:
19032125
5.

Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.

Hagiwara M, Delea TE, Stanford RH, Stempel DA.

Allergy Asthma Proc. 2010 May-Jun;31(3):203-10. doi: 10.2500/aap.2010.31.3359.

PMID:
20534183
6.

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.

Delea TE, Hagiwara M, Stanford RH, Stempel DA.

Clin Ther. 2008 Mar;30(3):560-71. doi: 10.1016/j.clinthera.2008.03.011.

PMID:
18405796
8.

Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.

Tunceli O, Williams SA, Kern DM, Elhefni H, Pethick N, Wessman C, Zhou S, Trudo F.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):719-26. doi: 10.1016/j.jaip.2014.07.016. Epub 2014 Oct 3.

9.

Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.

Hagiwara M, Delea TE, Stanford RH.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):54-62. doi: 10.2500/aap.2014.35.3720.

PMID:
24433597
11.
12.

Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.

O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.

Ann Allergy Asthma Immunol. 2004 Dec;93(6):581-8.

PMID:
15609769
13.
14.

Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.

O'Connor RD, Rosenzweig JR, Stanford RH, Gilmore AS, Ryskina KL, Legorreta AP, Stempel DA.

Ann Allergy Asthma Immunol. 2005 Dec;95(6):535-40.

PMID:
16400892
15.
16.

Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.

Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL.

Am J Geriatr Pharmacother. 2012 Dec;10(6):343-51. doi: 10.1016/j.amjopharm.2012.09.005. Epub 2012 Oct 17.

PMID:
23083688
17.

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.

Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR.

Respir Med. 2010 Apr;104(4):510-7. doi: 10.1016/j.rmed.2009.10.025. Epub 2009 Nov 26.

18.

Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.

Delea TE, Hagiwara M, Stempel DA, Stanford RH.

Allergy Asthma Proc. 2010 May-Jun;31(3):211-8. doi: 10.2500/aap.2010.31.3360.

PMID:
20615321
19.

Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.

Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.

Clin Ther. 2009 May;31(5):1056-63. doi: 10.1016/j.clinthera.2009.05.008.

PMID:
19539106
20.

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.

Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF.

Pharmacoeconomics. 2006;24(7):695-708. Erratum in: Pharmacoeconomics. 2008;26(10):894.

PMID:
16802845
Items per page

Supplemental Content

Write to the Help Desk